药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Formebolone
Pentaerythritol tetranitrate
Emopamil may increase the vasodilatory activities of Pentaerythritol tetranitrate.
Formebolone
Erythrityl tetranitrate
Emopamil may increase the vasodilatory activities of Erythrityl tetranitrate.
Formebolone
Amyl Nitrite
Emopamil may increase the vasodilatory activities of Amyl Nitrite.
Formebolone
Cenobamate
The serum concentration of Emopamil can be decreased when it is combined with Cenobamate.
Formebolone
Balaglitazone
The risk or severity of hypoglycemia can be increased when Emopamil is combined with Balaglitazone.
Formebolone
Ciglitazone
The risk or severity of hypoglycemia can be increased when Emopamil is combined with Ciglitazone.
Formebolone
Rivoglitazone
The risk or severity of hypoglycemia can be increased when Emopamil is combined with Rivoglitazone.
Formebolone
Netoglitazone
The risk or severity of hypoglycemia can be increased when Emopamil is combined with Netoglitazone.
Formebolone
Alogliptin
The risk or severity of hypoglycemia can be increased when Emopamil is combined with Alogliptin.
Formebolone
Gastric inhibitory polypeptide
The risk or severity of hypoglycemia can be increased when Emopamil is combined with Gastric inhibitory polypeptide.
Formebolone
Tirzepatide
The risk or severity of hypoglycemia can be increased when Emopamil is combined with Tirzepatide.
Formebolone
Englitazone
The risk or severity of hypoglycemia can be increased when Emopamil is combined with Englitazone.
Formebolone
Taspoglutide
The risk or severity of hypoglycemia can be increased when Emopamil is combined with Taspoglutide.
Formebolone
Semaglutide
The risk or severity of hypoglycemia can be increased when Emopamil is combined with Semaglutide.
Formebolone
Metahexamide
The risk or severity of hypoglycemia can be increased when Emopamil is combined with Metahexamide.
Formebolone
Guar gum
The risk or severity of hypoglycemia can be increased when Emopamil is combined with Guar gum.
Formebolone
Carbutamide
The risk or severity of hypoglycemia can be increased when Emopamil is combined with Carbutamide.
Formebolone
Remogliflozin etabonate
The risk or severity of hypoglycemia can be increased when Emopamil is combined with Remogliflozin etabonate.
Formebolone
Sotagliflozin
The risk or severity of hypoglycemia can be increased when Emopamil is combined with Sotagliflozin.
Formebolone
Evogliptin
The risk or severity of hypoglycemia can be increased when Emopamil is combined with Evogliptin.